1-5 of 5
Tusneem Elhassan
Close
Sort by
Journal Articles

Long Term Survival Analysis and Impact of Risk Factors Based Survival Model in Two Hundred Patients with Primary Refractory Hodgkin Lymphoma Who Underwent High Dose Chemotherapy and Autologous Stem Cell Transplant

Saad Akhtar, M Shahzad Rauf, Tusneem Elhassan, Z A Khan, Mahmoud Elshenawy, Irfan Maghfoor
Journal: Blood
Blood (2022) 140 (Supplement 1): 10594–10595.
https://doi.org/10.1182/blood-2022-164601
Published: 2022
Journal Articles

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Ali Alsugair, Syed O. Ahmed, Mohamed Isam Sharif, Tusneem Elhassan, Hazza A. Alzahrani, Fahed Almhareb, Naeem A. Chaudhri, Fahad Alsharif, Walid Rasheed, Amr Hanbali, Feras Abdulaziz Alfraih, Marwan Shaheen, Riad El Fakih, Saud Alhayli, Ali Alahmari, Alfadel Alshaibani, Abdulwahab Albabtain, Ahmad S. Alotaibi, Mansour Alfayez, Mahmoud Aljurf
Journal: Blood
Blood (2022) 140 (Supplement 1): 10566–10567.
https://doi.org/10.1182/blood-2022-167509
Published: 2022
Journal Articles

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Muhned Alhumaid, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Hazzaa Alzahrani, MD, Naeem A. Chaudhri, MD, Raid El Fakih, MD, Amr Hanbali, MD, Shahrukh K. Hashmi, MDMPH, Said Yousuf Ahmed, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Marwan Shaheen, MD, Tusneem Elhassan, MSc, Feras Abdulaziz Alfraih, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5498.
https://doi.org/10.1182/blood.V130.Suppl_1.5498.5498
Published: 2017
Journal Articles

Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): Clinical Features, Treatment, and Outcome. a Single Institution Result of 145 Patients from the Middle East

Saad Akhtar, MD, Amani Al-Kofide, MD, Nasir Bakshi, MD, Mohammed Shamayel, MD, Yasser Khafaga, MD, Suleimman Al-Sweedan, MD, Tusneem Elhassan, MSc, M S Rauf, MD, Irfan Maghfoor, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2794.
https://doi.org/10.1182/blood.V130.Suppl_1.2794.2794
Published: 2017
Journal Articles

Validation of Proposed European Leukemia Net Recommendations for Standardized Reporting and Classification of Cytogenetic Risk in AML Patients Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Wahiba Chebbo, M.D., Shad Ahmed, M.D., Fazal Hussain, M.D., Tusneem Elhassan, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4894.
https://doi.org/10.1182/blood.V118.21.4894.4894
Published: 2011